|
Post Intensive Care Unit Atrial Fibrillation
RECRUITINGN/ASponsored by Centre Hospitalier Universitaire de Besancon
Actively Recruiting
PhaseN/A
SponsorCentre Hospitalier Universitaire de Besancon
Started2023-09-19
Est. completion2026-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05860894
Summary
Atrial fibrillation (AF) is a common heart rhythm disorder in the intensive care unit (ICU). It can be precipitated by multiple factors but it is unclear whether AF persists after discharge from the ICU, and long term. This study will investigate whether AF recurs up to one year after ICU discharge.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Age \>18 years * New onset atrial fibrillation diagnosed in the ICU (12 lead ECG or documented episode of atrial fibrillation lasting at least 30 seconds) * Patient hospitalized in the ICU with at least one of the following two criteria: * orotracheal intubation for mechanical ventilation * AND/OR treatment with amines (vasopressors or inotropic agents) * Written informed consent * Patient affiliated to a social security regime (or beneficiary thereof) Exclusion Criteria: * Documented history of atrial fibrillation * patients admitted to the ICU after cardiothoracic surgery * Patients with life expectancy \<12 months * Patients under legal or judicial protection * Patients with no social security coverage * Patients within the exclusion period of another clinical trial
Conditions3
Atrial FibrillationCritical IllnessHeart Disease
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorCentre Hospitalier Universitaire de Besancon
Started2023-09-19
Est. completion2026-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05860894